[1]白雨昕.来曲唑联合克罗米芬治疗多囊卵巢综合征的有效性及安全性分析[J].医学信息,2023,36(10):168-171.[doi:10.3969/j.issn.1006-1959.2023.10.038]
　BAI Yu-xin.Analysis of the Efficacy and Safety of Letrozole Combined with Clomifene Citrate in the Treatment of Polycystic Ovary Syndrome[J].Journal of Medical Information,2023,36(10):168-171.[doi:10.3969/j.issn.1006-1959.2023.10.038]
点击复制

来曲唑联合克罗米芬治疗多囊卵巢综合征的有效性及安全性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年10期
页码:
168-171
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Analysis of the Efficacy and Safety of Letrozole Combined with Clomifene Citrate in the Treatment of Polycystic Ovary Syndrome
文章编号:
1006-1959（2023）10-0168-04
作者:
白雨昕
（佳木斯市中心医院妇科，黑龙江 佳木斯 154003）
Author(s):
BAI Yu-xin
(Department of Gynecology,Jiamusi Central Hospital,Jiamusi 154003,Heilongjiang,China)
关键词:
多囊卵巢综合征; 来曲唑; 克罗米芬; 性激素
Keywords:
Polycystic ovary syndrome; Letrozole; Clomifene citrate; Sex hormones
分类号:
R711.75
DOI:
10.3969/j.issn.1006-1959.2023.10.038
文献标志码:
A
摘要:
目的 研究来曲唑（LE）联合克罗米芬（CC）治疗多囊卵巢综合征（PCOS）的临床疗效及安全性。方法 纳入2020年1月-2022年1月佳木斯市中心医院妇科收治的60例PCOS患者，按照随机数字表法分为对照组（30例）与观察组（30例），对照组给予CC治疗，观察组给予LE联合CC治疗，比较两组临床疗效、性激素水平[雌二醇（E2）、卵泡刺激素（FSH）、黄体生成素（LH）]、子宫内膜厚度、卵泡数目及不良反应发生率。结果 观察组治疗总有效率为93.33%，高于对照组的76.67%（P＜0.05）；观察组治疗后E2、FSH、LH水平低于治疗前及对照组（P＜0.05）；观察组治疗后子宫内膜厚度、卵泡数目均小于治疗前及对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 LE联合CC治疗PCOS的疗效良好，可改善患者性激素水平，降低子宫内膜厚度及卵泡数量，且不增加不良反应。
Abstract:
Objective To study the clinical efficacy and safety of letrozole (LE) combined with clomifene citrate (CC) in the treatment of polycystic ovary syndrome (PCOS).Methods From January 2020 to January 2022, 60 patients with PCOS admitted to the Department of Gynecology of Jiamusi Central Hospital were included and divided into control group (30 patients) and observation group (30 patients) according to the random number table method. The control group was treated with CC, and the observation group was treated with LE combined with CC. The clinical efficacy, sex hormone levels [estradiol (E2), follicle stimulating hormone (FSH), luteinizing hormone (LH)], endometrial thickness, follicle number and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.33%, which was higher than 76.67% in the control group (P<0.05). After treatment, the levels of E2, FSH and LH in the observation group were lower than those before treatment and in the control group (P<0.05). After treatment, the endometrial thickness and the number of follicles in the observation group were less than those before treatment and in the control group. (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion LE combined with CC is effective in the treatment of PCOS, which can improve the level of sex hormones, reduce the thickness of endometrium and the number of follicles, and do not increase adverse reactions.

参考文献/References:

[1]高洁凡,王东晖,宋阳阳,等.来曲唑联合克罗米芬治疗多囊卵巢综合征患者的疗效及对排卵、妊娠情况的影响[J].中国妇产科临床杂志,2022,23(3):266-268.[2]曲红光,文陶非,张晓杰.来曲唑和氯米芬对多囊卵巢综合征不孕症患者促排卵治疗的临床效果观察[J].中国妇幼保健,2020,35(15):2859-2861.[3]覃晓,黎枝,覃卫玲,等.不同促排卵方案对多囊卵巢综合征不孕症患者的治疗效果[J].生殖医学杂志,2021,30(2):175-178.[4]王鑫,焦守凤,张占华.来曲唑联合克罗米芬治疗排卵障碍的疗效[J].中国计划生育学杂志,2020,28(11):1774-1777.[5]Yu Y,Fang L,Zhang R,et al.Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis[J].Scientific Reports,2017,7(1):3812.[6]任玮玮,孙林.促性腺激素释放激素激动剂、绒毛膜促性腺激素在枸橼酸氯米芬联合人绝经期促性腺激素促排卵治疗多囊卵巢综合征不孕中的应用效果比较[J].中国医师进修杂志,2020,43(6):560-563.[7]黄敬华,张丰萍.克罗米芬联合补佳乐与来曲唑用于多囊卵巢综合征促排卵助孕的临床研究[J].川北医学院学报,2019,34(6):791-793.[8]王志芳,杨丽娜,蔡宁.来曲唑联合氯米芬序贯治疗对多囊卵巢综合征患者性激素水平以及妊娠结局的影响[J].山西医药杂志,2019,48(21):2598-2600.[9]中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志,2018,53(1):2-6.[10]白淑芳,柏璐,白雅维,等.来曲唑分别联合氯米芬与尿促性腺激素治疗对多囊卵巢综合征患者血清性激素及COR水平的影响[J].解放军医药杂志,2019,31(8):95-99.[11]李砚,姚念玲,王运萍,等.来曲唑与克罗米芬治疗多囊卵巢综合征的疗效及对促排卵的效果比较[J].海南医学,2019,30(15):1965-1968.[12]徐晓航,张翠莲,张少娣,等.来曲唑联合克罗米芬促排卵在卵巢低反应患者中的应用[J].中国计划生育和妇产科,2018,10(11):84-87,96.[13]杨春伟,王晓涛,李秋云,等.不同方案超促排卵过程中黄体生成素水平对多囊卵巢综合征患者排卵的影响[J].中国煤炭工业医学杂志,2017,20(12):1411-1414.[14]孙静华.来曲唑与枸橼酸氯米芬治疗多囊卵巢不孕症疗效分析[J].中国优生与遗传杂志,2018,26(7):126-127.[15]Waseem S,Gohar S,Afzal M,et al.Comparison of Clomiphene Citrate Plus N-Acetyl Cysteine and Clomiphene Citrate Alone for Induction of Ovulation in Polycystic Ovary Syndrome[J].Pakistan Journal of Medical and Health Sciences,2021,15(6):1253-1255.[16]郭瑶,杨金娜,于跃辉.来曲唑与克罗米芬治疗多囊卵巢综合征不孕症临床疗效比较[J].临床军医杂志,2018,46(3):359-361.[17]杨波,陈慧春,王德佳,等.来曲唑对多囊卵巢综合征患者子宫内膜厚度分型及性激素水平影响[J].河北医学,2017,23(11):1909-1912.[18]崔荣荣,王晨鸽,尹东升.来曲唑联合克罗米芬治疗多囊卵巢综合征疗效观察[J].陕西医学杂志,2022,51(3):359-362.[19]焦守凤,刘桂娟,李娜.来曲唑、克罗米芬单用或联合应用对多囊卵巢综合征不孕症患者尿促性素用量及排卵效果的影响[J].中国计划生育和妇产科,2018,10(8):75-78.[20]Ghasemian F,Esmaeilnezhad S.Comparison of Metformin, Clomiphene Citrate, and Flutamide Effects on Quality and Ultrastructure Status of the Oocyte, and Embryo Development in a PCOS-mouse Model[J].Reproductive BioMedicine Online,2022,45(2):191-201.[21]Mohammad GR,Masomeh H,Meisam D,et al.Erratum: Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome[J].Drug Des Devel Ther,2017,28(11):1367-1368.[22]Allaway HCM,Chizen DR,Adams GP,et al.Effects of a single 20 mg dose of letrozole on ovarian function post dominant follicle selection: an exploratory randomized controlled trial[J].Journal of Ovarian Research,2017,10(1):6.[23]何丽,赵勇,李敏,等.来曲唑序贯氯米芬在多囊卵巢综合征患者中的应用[J].实用妇产科杂志,2017,33(1):27-30.

相似文献/References:

[1]袁 奔,潘 伟,罗淑红,等.体重指数对多囊卵巢综合征患者 人工授精妊娠结局影响[J].医学信息,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
　YUAN Ben,PAN Wei,LUO Shu-hong,et al.Effects of Body Mass Index on the Outcome of Artificial Insemination in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2018,31(10):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
[2]罗红财,沈 颖,黄莉珊,等.基于温肾助阳、暖宫温胞改善卵巢功能异常的机制分析[J].医学信息,2022,35(11):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
　LUO Hong-cai,SHEN Ying,HUANG Li-shan,et al.The Mechanism Analysis of Improve Symptoms Related to Ovarian Dysfunction Based on Warming Kidney and Helping Yang,Warming Baogong[J].Journal of Medical Information,2022,35(10):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
[3]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
　ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Journal of Medical Information,2019,32(10):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[4]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
　CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2022,35(10):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[5]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
　ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Journal of Medical Information,2022,35(10):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[6]谢 丹.不同促排卵方案治疗多囊卵巢综合征不孕症的效果[J].医学信息,2020,33(18):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
　XIE Dan.The Effect of Different Ovulation Induction Programs on the Infertility of Polycystic Ovary Syndrome[J].Journal of Medical Information,2020,33(10):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
[7]朱 艳,周 琴,安 洁,等.脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究[J].医学信息,2020,33(22):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
　ZHU Yan,ZHOU Qin,AN Jie,et al.Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance[J].Journal of Medical Information,2020,33(10):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
[8]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
　WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Journal of Medical Information,2020,33(10):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[9]王争艳,宋发荣.中药月经周期疗法治疗PCOS不孕症的效果[J].医学信息,2020,33(20):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
　WANG Zheng-yan,SONG Fa-rong.The Effect of Chinese Medicine Menstrual Cycle Therapy on PCOS Infertility[J].Journal of Medical Information,2020,33(10):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
[10]袁 瑞,余亚莉.吡格列酮二甲双胍片治疗胰岛素抵抗型多囊卵巢综合征患者的疗效[J].医学信息,2021,34(01):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
　YUAN Rui,YU Ya-li.Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets in the Treatment of Patients with Insulin-resistant Polycystic Ovary Syndrome[J].Journal of Medical Information,2021,34(10):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
[11]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的 临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
　LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2018,31(10):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]

更新日期/Last Update: 1900-01-01